Celmatix Secures $3,757,754 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    54 West 40th St. New York, NY 10018 USA
  • Company Description
    Celmatix, Inc. is a New York City-based biotechnology company targeting the reproductive medicine sector with products designed to improve reproductive technologies and outcomes.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor

Trending on Xconomy